<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-pharmaceutics-13-00387">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aguilar-Díaz</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>García-Montoya</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Suñe-Negre</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Pérez-Lozano</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Miñarro</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ticó</surname>
    <given-names>J.R.</given-names>
   </name>
  </person-group>
  <article-title>Predicting orally disintegrating tablets formulations of ibuprophen tablets: An application of the new SeDeM-ODT expert system</article-title>
  <source>Eur. J. Pharm. Biopharm.</source>
  <year>2012</year>
  <volume>80</volume>
  <fpage>638</fpage>
  <lpage>648</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejpb.2011.12.012</pub-id>
  <pub-id pub-id-type="pmid">22245156</pub-id>
 </element-citation>
</ref>
